These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16775432)

  • 21. Outcome of liver transplantation for hepatocellular carcinoma -- a single center experience.
    Iacob R; Iacob S; Gheorghe L; Gheorghe C; Hrehoreţ D; Brașoveanu V; Croitoru A; Herlea V; Popescu I
    Chirurgia (Bucur); 2013; 108(4):446-50. PubMed ID: 23958083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
    Fernandez-Sevilla E; Allard MA; Selten J; Golse N; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Adam R
    Liver Transpl; 2017 Apr; 23(4):440-447. PubMed ID: 28187493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation.
    Zhang W; Kim R; Quintini C; Hashimoto K; Fujiki M; Diago T; Eghtesad B; Miller C; Fung J; Tan A; Menon KV; Aucejo F
    Liver Transpl; 2015 Jan; 21(1):101-11. PubMed ID: 25283528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma].
    Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ
    Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
    Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.
    Paschoal JP; Bernardo V; Canedo NH; Ribeiro OD; Caroli-Bottino A; Pannain VL
    BMC Cancer; 2014 Feb; 14():72. PubMed ID: 24507660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation.
    Guerrini GP; Pinelli D; Di Benedetto F; Marini E; Corno V; Guizzetti M; Aluffi A; Zambelli M; Fagiuoli S; Lucà MG; Lucianetti A; Colledan M
    Surg Oncol; 2016 Dec; 25(4):419-428. PubMed ID: 26403621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance.
    Tanigawa N; Lu C; Mitsui T; Miura S
    Hepatology; 1997 Nov; 26(5):1216-23. PubMed ID: 9362365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.
    Wang WQ; Liu L; Xu HX; Luo GP; Chen T; Wu CT; Xu YF; Xu J; Liu C; Zhang B; Long J; Tang ZY; Yu XJ
    PLoS One; 2013; 8(8):e71189. PubMed ID: 23940715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.
    Niedergethmann M; Hildenbrand R; Wostbrock B; Hartel M; Sturm JW; Richter A; Post S
    Pancreas; 2002 Aug; 25(2):122-9. PubMed ID: 12142733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.
    Sapisochin G; Bilbao I; Balsells J; Dopazo C; Caralt M; Lázaro JL; Castells L; Allende H; Charco R
    World J Surg; 2010 Sep; 34(9):2146-54. PubMed ID: 20411387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1626-30. PubMed ID: 17359695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of angiostatin, vascular endothelial growth factor, matrix metalloproteinase 9 and 12 in the angiogenesis of hepatocellular carcinoma].
    Kim S; Park HS; Son HJ; Moon WS
    Korean J Hepatol; 2004 Mar; 10(1):62-72. PubMed ID: 15096718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation.
    Li H; Wang S; Wang G; Zhang Z; Wu X; Zhang T; Fu B; Chen G
    Dig Surg; 2014; 31(6):468-78. PubMed ID: 25632982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microvessel density of hepatocellular carcinoma: its relationship with prognosis.
    Sun HC; Tang ZY; Li XM; Zhou YN; Sun BR; Ma ZC
    J Cancer Res Clin Oncol; 1999 Jul; 125(7):419-26. PubMed ID: 10394963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome.
    Chan KM; Chou HS; Wu TJ; Lee CF; Yu MC; Lee WC
    Asian J Surg; 2011 Jul; 34(3):128-34. PubMed ID: 22208688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.
    Chen L; Shi Y; Jiang CY; Wei LX; Lv YL; Wang YL; Dai GH
    Int J Biol Markers; 2011; 26(2):108-16. PubMed ID: 21574155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.